AzTrials
AzTrials

Medication ManagementNCT06018662

An Interventional Study to Establish a Medication Management Mobile Application for Pediatric Surgery Patients

A study testing A medication management mobile application in people with Medication Management, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

An interventional study that aims to design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department, and assess the impact of the implementation of an electronic medication management application on the… Read more about this study

Who is it for?
Ages 1 year to 12 years
Conditions the study is for
Medication Management
What is being tested?
A medication management mobile application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
276 participants
Where
1 siteEgypt
Study dates
1 Nov 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Pediatric patients undergoing any of the following surgeries: Circumcision, Inguinal Hernia, Hypospadias, Esophageal dilatation, uncomplicated Appendectomy, and complicated Appendectomy

Who cannot join

  • Cardiac patients
  • Diabetic patients
  • Hypertensive patients
  • Immunocompromised patients
  • Patients with renal and/or liver failure

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Ain Shams University

    Cairo, Nasr City

    Mai Fawaz, Master's

    Recruiting

Other trials in Egypt

About this study

Official title: Establishment of an Electronic Medication Management Application in a Pediatric Surgery Department

An interventional study that aims to design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department, and assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department

Read the detailed description

Mobile health (mHealth) refers to digital health technologies via mobile phones, tablets, and other electronic devices to enhance health outcomes. mHealth has started to have an impact on many health care and medical education aspects. With the increased number of smartphones and increasing interest in using mobile applications (apps), healthcare related mobile apps offer opportunities for advanced patient care allowing for better patient-provider communication. Within anesthesia, mobile apps were developed to play an important role; pre, intra- and postoperatively through providing patient-physician communication, reducing patient anxiety, and offering on-the-go education.

The development of medical mobile app is challenging. It incorporates producing an easy-to-use display with appropriate clinical information. Although many medication errors lead to little or no harm, some have overwhelming consequences for patients and, sometimes, for practitioners.

In pediatric patients, doses of anesthetics and other medications are calculated based on age and/or weight. Also, preparations often require further dilutions, specifically for younger patients like neonates and infants. These steps might increase risk for medication errors in pediatric anesthesia. For pediatric patients, it is important to use appropriate weight-based medication doses.

Anesthetics, Antimicrobials and Analgesics are the three drug classes that have shown the highest number of medication errors in the operating rooms of a pediatric surgery department. To provide an appropriate age and/or weight-based drug information, we will develop an electronic application to recommend the most appropriate drugs based on international guidelines and calculate doses for Anesthetics, Antimicrobials and Analgesics for pediatric patients in the operating rooms of a pediatric surgery department.

Aim of the study:

To design, establish and implement an electronic application for management of the usage of anesthetics, antimicrobials, and analgesics in a pediatric surgery department. To assess the impact of the implementation of an electronic medication management application on the appropriateness of medication use in a pediatric surgery department

Patients and methods:

Design:

Prospective, Interventional, Single-blinded, Randomized controlled study.

Setting:

The study will be conducted in the pediatric surgery department in the Children's hospital, Ain Shams University, Cairo, Egypt.

Patients:

Pediatric patients undergoing surgical operations.

Methods:

The study will be performed according to the following phases;

Phase 1: Application Design and Development

  • The app will include all database required to provide appropriate medications and dosing for pediatric patients intraoperatively, postoperatively and on discharge.
  • The user will need to enter the patient's age and weight, choose the type of surgery and the drug class and the app will show the appropriate medications and dosage.
  • The app will present all the important information for drug administration by using; the British National Formulary for children (BNF-C) and Lexicomp online database as the dosage and administration references, and The American Health System Pharmacists (ASHP) clinical practice guidelines and UpToDate evidence-based clinical decision support resource will be used for to determine the appropriate anesthetics, antimicrobials, and analgesics for the surgeries to be included in the study.
  • The researcher will ensure that the application will be displayed properly on the iPhone operating system (iOS) and Android mobile devices.

Phase 2: Simulation and Validation

  • To test app validation, a simulation study will be conducted, where, data of patient's weight and age will be entered followed by selection of type of surgery and drug class.
  • The app will provide the appropriate medications and dosage for each case scenario according to international treatment protocols and guidelines.
  • Medications doses in each drug class will be calculated twice using the app and twice without the app, for each type of surgery.

Phase 3: Physicians' training Physicians will be trained on how to use the application for the selected types of surgeries. (List of surgeons will be accurately checked and randomly 50% of them will be allowed to enter training sessions for use of app in their practice (interventional group), while the rest 50% will not be given the training sessions in order to use the department policy (Control group).

Phase 4: Patients' recruitment and Application use in pre-, intra-, and post-operative stage Two hundred and seventy- six 276 patients will be randomly allocated to either control group or intervention group via simple randomization technique.

Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the app.

Intervention group (138 patients): The physicians use the app for appropriate medications selection and dosage calculation.

All patients will be followed up postoperatively during hospital stay. A follow-up form will be used to record all required data during hospitalization.

Cost estimation :

Estimated cost savings will be calculated based on reduction in medication errors by using the electronic app. This will include discontinuing unnecessary medications, modifications of dose or duration, no medication indication, and inappropriate medication combination.

Medication errors categories according to the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) will be included in the cost saving analysis.

Phase 5: Usability testing An electronic form of the System Usability Scale (SUS), a widely used and validated 10-questions Likert scale, for measuring the app usability will be used to evaluate physicians' user experience of the app.

Phase 6: Follow-up All patients will be followed up for two weeks after discharge for any signs and symptoms of drug related problems or postoperative complications including pain, nausea, vomiting and surgical site infection using an electronic form or phone calls. A follow-up form will be used after discharge

Being tested
A medication management mobile application
Keywords
Pediatric surgery, Mobile application, Medication errors

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • A medication management mobile applicationOther

    A mobile application to select the most appropriate drugs for anesthetics, antimicrobials and analgesics, in addition to dose calculations

Study groups in NCT06018662
Study groupRoleWhat they receive
ControlNo interventionRoutine department therapy
InterventionalExperimentalAnesthetics, antimicrobials and analgesics are selected and age/weight doses are calculated using the medication management mobile application
Receives: Other: A medication management mobile application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Appropriateness of medications (anesthetics, antimicrobials, and analgesics) used in different types of surgeries

    Determined through measuring incidence of medication errors and drug related problems

    Measured: One year

Secondary outcomes (3)
  1. Cost saving

    Estimated cost savings will be calculated by calculating direct medical costs (including medication costs (multiplied by duration in days) of the intervened medications if the interventions belong to any of the mentioned types, laboratory tests, investigations and hospital care).

    Estimated cost avoidance will be calculated based on the probability score (probability of an adverse drug event in the absence of the intervention).

    Measured: One year

  2. Cost avoidance

    Estimated cost avoidance will calculated based on the probability of an adverse drug event in the absence of the mobile application

    Measured: one year

  3. Time saving

    Time saving resulting from using the application will be calculated in seconds

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2023
  2. Study start1 Nov 2023
  3. Primary completion1 Oct 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Control group (138 patients): The medications selection and dosage will be performed according to the department policy without using the application. Intervention group (138 patients): The physicians use the application for appropriate medications selection and dosage calculation.
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
276 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06018662
Sponsor's protocol ID
A medication mobile app
Status last verified
Jan 2024
First submitted
3 Aug 2023
Last updated
31 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing A medication management mobile application in people with Medication Management, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mai Fawaz, Master's (+20 1221190802, May.gamal21@pharma.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Appropriateness of medications (anesthetics, antimicrobials, and analgesics) used in different types of surgeries (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in